PHGDH inhibitors (Takeda Pharmaceutical/Xtal Biostructures)

N/A

Report date: 2025/03/20 10:10:17
NME

Base Information

Drug NamePHGDH inhibitors (Takeda Pharmaceutical/Xtal Biostructures)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionD-3-phosphoglycerate dehydrogenase inhibitors
TargetsD-3-phosphoglycerate dehydrogenase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXTAL BioStructures IncTakeda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A